相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer
Alex J. Walsh et al.
CANCER RESEARCH (2013)
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
C. McCowan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Oxidants, antioxidants and the current incurability of metastatic cancers
Jim Watson
OPEN BIOLOGY (2013)
COX-2 in cancer: Gordian knot or Achilles heel?
Ioannis Stasinopoulos et al.
FRONTIERS IN PHARMACOLOGY (2013)
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
Sarah Crawford
FRONTIERS IN PHARMACOLOGY (2013)
Clinical evidence for the use of aspirin in the treatment of cancer
Ruth E. Langley
ECANCERMEDICALSCIENCE (2013)
Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy
Subash C. Gupta et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Vitamin D and cancer: a review of molecular mechanisms
James C. Fleet et al.
BIOCHEMICAL JOURNAL (2012)
Use of Aspirin postdiagnosis improves survival for colon cancer patients
E. Bastiaannet et al.
BRITISH JOURNAL OF CANCER (2012)
Effect of aspirin (ASP) or celecoxib (CC) use on outcomes in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27
M. J. Higgins et al.
CANCER RESEARCH (2012)
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency
Sigrid Hatse et al.
CARCINOGENESIS (2012)
Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy
Nicholas G. Zaorsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
Kevin S. Choe et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
Goran Bjelakovic et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment A new genetically tractable model for human cancer associated fibroblasts
Casey Trimmer et al.
CANCER BIOLOGY & THERAPY (2011)
Vitamin Supplement Use During Breast Cancer Treatment and Survival: A Prospective Cohort Study
Sarah Nechuta et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species
Santhi Achuthan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Aspirin and colorectal cancer prevention in Lynch syndrome
Andrew T. Chan et al.
LANCET (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
C. Davies et al.
LANCET (2011)
Transcriptional evidence for the Reverse Warburg Effect in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and Neuron-Glia Metabolic Coupling
Stephanos Pavlides et al.
AGING-US (2010)
Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
Agnieszka K. Witkiewicz et al.
CANCER BIOLOGY & THERAPY (2010)
Understanding the lethal drivers of tumor-stroma co-evolution Emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment
Michael P. Lisanti et al.
CANCER BIOLOGY & THERAPY (2010)
The reverse Warburg effect Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts
Gloria Bonuccelli et al.
CELL CYCLE (2010)
The autophagic tumor stroma model of cancer Role of oxidative stress and ketone production in fueling tumor cell metabolism
Stephanos Pavlides et al.
CELL CYCLE (2010)
Ketones and lactate fuel tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli et al.
CELL CYCLE (2010)
Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2010)
Autophagy in cancer associated fibroblasts promotes tumor cell survival Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2010)
Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the reverse Warburg effect A transcriptional informatics analysis with validation
Stephanos Pavlides et al.
CELL CYCLE (2010)
Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation Implications for breast cancer and DCIS therapy with autophagy inhibitors
Ubaldo E. Martinez-Outschoorn et al.
CELL CYCLE (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer
Erica K. Sloan et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
Agnieszka K. Witkiewicz et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
Agnieszka K. Witkiewicz et al.
CANCER BIOLOGY & THERAPY (2009)
An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation
Dolores Di Vizio et al.
CELL CYCLE (2009)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation - Implications for the response to hormonal therapy
Isabelle Mercier et al.
CANCER BIOLOGY & THERAPY (2008)
Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis
Kaori Ishikawa et al.
SCIENCE (2008)
A unified model of sigmoid tumour growth based on cell proliferation and quiescence
F. Kozusko et al.
CELL PROLIFERATION (2007)
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
Goran Bjelakovic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Dietary polyphenolic phytochemicals - Promising cancer chemopreventive agents in humans? A review of their clinical properties
Sarah C. Thomasset et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Endogenous markers of two separate, hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial
MI Koukourakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
CM Ulrich et al.
NATURE REVIEWS CANCER (2006)
Use of antioxidants during chemotherapy and radiotherapy should be avoided
GM D'Andrea
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer
D Pereg et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Drug resistance in cancer: Principles of emergence and prevention
NL Komarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Modulation of skin tumorigenesis by SOD
D St Clair et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Mechanism of the tumor suppressive effect of MnSOD overexpression
LW Oberley
BIOMEDICINE & PHARMACOTHERAPY (2005)
Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells
S Venkataraman et al.
ONCOGENE (2005)
Inflammation and Cancer - II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy
M Macarthur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Inflammation as a tumor promoter in cancer induction
M Philip et al.
SEMINARS IN CANCER BIOLOGY (2004)
Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
SH Itzkowitz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Mitochondrial superoxide dismutase: A promising target for new anticancer therapies
G Pani et al.
CURRENT MEDICINAL CHEMISTRY (2004)
MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells
H Duan et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
Inflammation and the development of pancreatic cancer
B Farrow et al.
SURGICAL ONCOLOGY-OXFORD (2002)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Helicobacter pylori and gastrointestinal tract adenocarcinomas
RM Peek et al.
NATURE REVIEWS CANCER (2002)
The role of cyclooxygenase inhibitors in cancer prevention
WF Anderson et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Prostaglandin E-2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
R Pai et al.
NATURE MEDICINE (2002)
Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia
P Wardman
CURRENT MEDICINAL CHEMISTRY (2001)
Anticancer therapy by overexpression of superoxide dismutase
LW Oberley
ANTIOXIDANTS & REDOX SIGNALING (2001)
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells
HM Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mechanisms of anti-cancer agents: Emphasis on oxidative stress and electron transfer
P Kovacic et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
分享论文
